# How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment

> **NCT00595361** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 30 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** salmeterol

## Key facts

- **NCT ID:** NCT00595361
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-05
- **Final completion:** 2012-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595361, "How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00595361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*